Literature DB >> 19083014

Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.

Matthew E Talbert1, Carl D Langefeld, Julie Ziegler, Josyf C Mychaleckyj, Steven M Haffner, Jill M Norris, Donald W Bowden.   

Abstract

The SOCS3 gene product participates in the feedback inhibition of a range of cytokine signals. Most notably, SOCS3 inhibits the functioning of leptin and downstream steps in insulin signaling after being expressed by terminal transcription factors, such as STAT3 and c-fos. The SOCS3 gene is located in the chromosome region 17q24-17q25, previously linked to body mass index (BMI), visceral adipose tissue (VAT), and waist circumference (WAIST) in Hispanic families in the Insulin Resistance Atherosclerosis Family Study (IRASFS). A high density map of 1,536 single nucleotide polymorphisms (SNPs) was constructed to cover a portion of the 17q linkage interval in 1,425 Hispanic subjects from 90 extended families in IRASFS. Analysis of this dense SNP map data revealed evidence of association of rs9914220 (located 10 kb 5' of the SOCS3 gene) with BMI, VAT, and WAIST (P-value ranging from 0.003 to 0.017). Using a tagging SNP approach, rs9914220 and 22 additional SOCS3 SNPs were genotyped for genetic association analysis with measures of adiposity and glucose homeostasis. The adiposity phenotypes utilized in association analyses included BMI, WAIST, waist to hip ratio (WHR), subcutaneous adipose tissue, VAT, and visceral to subcutaneous ratio (VSR). Linkage disequilibrium calculations revealed three haplotype blocks near SOCS3. Haplotype Block 3 (5' of SOCS3) contained SNPs consistently associated with BMI, WAIST, WHR, and VAT (P-values ranging from 2.00 x 10(-4) to 0.036). Haplotype Block 1 contained single-SNPs that were associated with most adiposity traits except for VSR (P-values ranging from 0.002 to 0.047). When trait associated SNPs were included in linkage analyses as covariates, a reduction of VAT LOD score from 1.26 to 0.76 above the SOCS3 locus (110 cM) was observed. Multi-SNP haplotype testing using the quantitative pedigree disequilibrium test was broadly consistent with the single-SNP associations. In conclusion, these results support a role for SOCS3 genetic variants in human obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083014      PMCID: PMC2804661          DOI: 10.1007/s00439-008-0608-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

1.  Zero-recombinant haplotyping: applications to fine mapping using SNPs.

Authors:  J R O'Connell
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.

Authors:  Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich
Journal:  Ann Epidemiol       Date:  2003-04       Impact factor: 3.797

Review 4.  Suppressors of cytokine signalling: SOCS.

Authors:  Lykke Larsen; Carsten Röpke
Journal:  APMIS       Date:  2002-12       Impact factor: 3.205

Review 5.  Molecular pathways to obesity.

Authors:  K G Hofbauer
Journal:  Int J Obes Relat Metab Disord       Date:  2002-09

6.  Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity.

Authors:  T Gylvin; R Nolsøe; T Hansen; E M D Nielsen; R Bergholdt; A E Karlsen; N Billestrup; K Borch-Johnsen; O Pedersen; T Mandrup-Poulsen; J Nerup; F Pociot
Journal:  Diabetologia       Date:  2004-07-13       Impact factor: 10.122

7.  Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.

Authors:  Stephen S Rich; Donald W Bowden; Steven M Haffner; Jill M Norris; Mohammed F Saad; Braxton D Mitchell; Jerome I Rotter; Carl D Langefeld; Lynne E Wagenknecht; Richard N Bergman
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

8.  Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling.

Authors:  Hang Shi; Iphigenia Tzameli; Christian Bjørbaek; Jeffrey S Flier
Journal:  J Biol Chem       Date:  2004-06-04       Impact factor: 5.157

9.  Analysis of SOCS-3 promoter responses to interferon gamma.

Authors:  Luana Gatto; Chiara Berlato; Valeria Poli; Silvia Tininini; Ichiko Kinjyo; Akihiko Yoshimura; Marco A Cassatella; Flavia Bazzoni
Journal:  J Biol Chem       Date:  2004-01-23       Impact factor: 5.157

10.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  18 in total

1.  Exploring differences in adiposity in two U.S. Hispanic populations of Mexican origin using social, behavioral, physiologic and genetic markers: the IRAS Family Study.

Authors:  Kendra A Young; Tasha E Fingerlin; Carl D Langefeld; Carlos Lorenzo; Steven M Haffner; Lynne E Wagenknecht; Jill M Norris
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

2.  Association of two polymorphisms within and near SOCS3 gene with obesity in three nationalities in Xinjiang province of China.

Authors:  Wei Tang; Jun-jie Zou; Xiang-fang Chen; Jiao-yang Zheng; Hua-zong Zeng; Zhi-min Liu; Yong-quan Shi
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

Review 3.  Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States.

Authors:  Cristina Aguayo-Mazzucato; Paula Diaque; Sonia Hernandez; Silvia Rosas; Aleksandar Kostic; Augusto Enrique Caballero
Journal:  Diabetes Metab Res Rev       Date:  2018-12-04       Impact factor: 4.876

Review 4.  Genetic variation in satiety signaling and hypothalamic inflammation: merging fields for the study of obesity.

Authors:  Alexandria Maria Szalanczy; Chia-Chi Chuang Key; Leah Catherine Solberg Woods
Journal:  J Nutr Biochem       Date:  2021-12-20       Impact factor: 6.048

5.  Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity.

Authors:  Ke Xu; Xinyu Zhang; Zuoheng Wang; Ying Hu; Rajita Sinha
Journal:  Biol Psychol       Date:  2016-11-05       Impact factor: 3.251

6.  Correlation of lipid metabolic disturbance with SOCS-3 gene variation in the Uygur nationality women in Xinjiang.

Authors:  Jing Hong; Jing Gao; Niluofeier Aierken; Dilinigeer Tuerxun; Mayila Kamilijiang; Nuerguli Maimaiti; Gui-Juan Chang; Nan-Fang Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

7.  Lack of association between suppressor of cytokine signaling-3 gene polymorphism and susceptibility and curve severity of adolescent idiopathic scoliosis.

Authors:  Feng Zhu; Jun Qiao; Xusheng Qiu; Leilei Xu; Zhen Liu; Zezhang Zhu; Bangping Qian; Xu Sun; Yong Qiu
Journal:  Eur Spine J       Date:  2014-07-18       Impact factor: 3.134

Review 8.  The genetic contribution to non-syndromic human obesity.

Authors:  Andrew J Walley; Julian E Asher; Philippe Froguel
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

9.  Suppressor of cytokine signaling 3 A+930-->G (rs4969168) polymorphism is associated with apolipoprotein A1 and low-density lipoprotein cholesterol.

Authors:  Tao Guo; Rui-Xing Yin; Rong-Jun Nie; Xia Chen; Yuan Bin; Wei-Xiong Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 10.  Obesity pharmacotherapy: current perspectives and future directions.

Authors:  Monika Misra
Journal:  Curr Cardiol Rev       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.